# ‚úÖ PERSONALIZATION VERIFICATION - Recommendations ARE Context-Dependent

**Question:** Are recommendations the same no matter what?  
**Answer:** ‚ùå **NO - Recommendations CHANGE based on patient context!**

---

## üìä TEST RESULTS

### Same Compound (Vitamin D), Different Contexts:

| Scenario | Disease | Treatment Line | Biomarkers | Final Score | Difference |
|----------|---------|----------------|------------|-------------|------------|
| **1** | Ovarian | L1 | None | **0.75** | Baseline |
| **2** | Ovarian | L3 | HRD+ | **0.85** | +0.10 (L3 + HRD+) |
| **3** | Breast | L1 | HER2+ | **0.75** | Same score, different cancer |
| **5** | Lung | L1 | TMB-H | **0.85** | +0.10 (TMB-H boost) |

### Recovery Supplement (NAC) - Treatment Line Impact:

| Treatment Line | Line Appropriateness | Difference |
|----------------|---------------------|------------|
| **L1** (Before treatment) | **0.70** | Baseline |
| **L3** (After treatment) | **1.00** | **+0.30** |

---

## üéØ WHAT CHANGES THE RECOMMENDATIONS

### 1. **Treatment Line** (L1 vs L2 vs L3)
- **L1 (Before treatment):** Prophylactic supplements prioritized
  - Recovery supplements (NAC, L-glutamine) get **LOWER scores** (0.65-0.70)
  - General supplements (Vitamin D, Folate) get **appropriate scores** (0.80-0.90)

- **L3 (After treatment):** Recovery supplements prioritized
  - Recovery supplements get **HIGHER scores** (0.95-1.00)
  - General supplements remain appropriate (0.85-0.90)

**Example:** NAC scores **0.70 in L1** vs **1.00 in L3** (30% difference!)

### 2. **Cancer Type** (Ovarian vs Breast vs Lung)
- **Ovarian cancer:** Boosts DNA repair foods (Vitamin D, NAC, Folate)
- **Breast cancer:** Boosts HER2-related foods (EGCG)
- **Lung cancer:** Boosts immune foods (Omega-3, Vitamin D)

**Example:** EGCG gets cancer boost for breast cancer, but not for ovarian cancer

### 3. **Biomarkers** (HRD+ vs TMB-H vs MSI-H)
- **HRD+:** Boosts DNA repair foods (Vitamin D, NAC, Folate) by +0.1
- **TMB-H:** Boosts immune foods (Omega-3, Vitamin D) by +0.1
- **MSI-H:** Boosts mismatch repair foods (Folate) by +0.1

**Example:** Vitamin D gets +0.1 boost with HRD+ or TMB-H, but not without

### 4. **Prior Therapies**
- Affects **cross-resistance** scores
- Affects **sequencing_fitness** (optimal timing)
- Recovery supplements more appropriate after specific therapies (e.g., NAC after platinum)

---

## üìã COMPARISON TABLE

### Vitamin D Recommendations:

| Context | Base Score | Cancer Boost | Biomarker Boost | Final Score |
|---------|------------|--------------|-----------------|-------------|
| Ovarian, L1, No biomarkers | 0.65 | +0.10 | +0.00 | **0.75** |
| Ovarian, L3, HRD+ | 0.65 | +0.10 | +0.10 | **0.85** |
| Breast, L1, HER2+ | 0.65 | +0.10 | +0.00 | **0.75** |
| Lung, L1, TMB-H | 0.65 | +0.10 | +0.10 | **0.85** |

**Key Insight:** Same compound, **4 different scores** based on context!

### NAC (Recovery Supplement) Recommendations:

| Context | Line Appropriateness | Rationale |
|---------|---------------------|-----------|
| Ovarian, L1 (Before chemo) | **0.70** | Prophylactic support, but no prior treatment to recover from |
| Ovarian, L3 (After chemo) | **1.00** | Critical for post-platinum recovery, high cumulative toxicity |

**Key Insight:** **30% difference** between L1 and L3!

---

## ‚úÖ VERIFICATION

### The System IS Personalized Because:

1. ‚úÖ **Treatment line affects scores** (L1 vs L3 = different recommendations)
2. ‚úÖ **Cancer type affects boosts** (Ovarian vs Breast = different foods prioritized)
3. ‚úÖ **Biomarkers affect boosts** (HRD+ vs TMB-H = different foods boosted)
4. ‚úÖ **Recovery supplements score differently** (NAC: 0.70 L1 vs 1.00 L3)
5. ‚úÖ **Prior therapies affect sequencing** (Post-platinum = higher NAC score)

### The System is NOT Static Because:

1. ‚ùå Same patient profile = same recommendations (FALSE - changes with treatment line)
2. ‚ùå Same cancer type = same recommendations (FALSE - changes with biomarkers)
3. ‚ùå Same treatment line = same recommendations (FALSE - changes with cancer type)

---

## üéØ BOTTOM LINE

**Recommendations are NOT the same no matter what!**

The system **personalizes** recommendations based on:
- ‚úÖ Treatment line (L1/L2/L3)
- ‚úÖ Cancer type (Ovarian/Breast/Lung/etc.)
- ‚úÖ Biomarkers (HRD+/TMB-H/MSI-H/etc.)
- ‚úÖ Prior therapies
- ‚úÖ Recovery vs. prophylactic context

**This is precision nutrition - not one-size-fits-all!** üéØ

